We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Celecoxib

News List

BioDelivery Sciences to Acquire U.S. and Canadian Rights to ELYXYB™ for Migraine Treatment americanpharmaceuticalreview
August 05, 2021
BioDelivery Sciences International Inc., a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, announced that it entered into an agreement on August 3, 2021 with Dr. Reddy’s Laboratories ...
Two anti-inflammatory drugs may inhibit COVID-19 virus reproduction expresspharma
May 29, 2020
The findings show that at a concentration of 50 micromolar (μM) of Celecoxib or Carprofen, the inhibition of the in vitro activity of M-pro enzyme is 11.90 and 4.0 per cent, respectively.
Celecoxib shows potential benefit for Duchenne muscular dystrophy europeanpharmaceuticalreview
May 09, 2018
Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy…